Understanding the Disease Course and Therapeutic Benefit of Tafamidis Across Real-World Studies of Hereditary Transthyretin Amyloidosis with Polyneuropathy: A Proof of Concept for...

por Serrano, Daniel, Atzinger, Christopher B., Botteman, Marc F.
Publicado 2018

Economic Impact of Antidiabetic Medications and Glycemic Control on Managed Care Organizations: A Review of the Literature

por Stephens, Jennifer M., Botteman, Marc F., Hay, Joel W.
Publicado 2006

Modelling the cost-effectiveness of combination therapy for early, rapidly progressing rheumatoid arthritis by simulating the reversible and irreversible effects of the disease

por Stephens, Stephanie, Botteman, Marc F, Cifaldi, Mary A, van Hout, Ben A
Publicado 2015

Impact of Non-Cardiac Clinicopathologic Characteristics on Survival in Transthyretin Amyloid Polyneuropathy

por González‐Duarte, Alejandra, Conceição, Isabel, Amass, Leslie, Botteman, Marc F., Carter, John A., Stewart, Michelle
Publicado 2020

Mapping of the Insomnia Severity Index and other sleep measures to EuroQol EQ-5D health state utilities

por Gu, Ning Yan, Botteman, Marc F, Ji, Xiang, Bell, Christopher F, Carter, John A, van Hout, Ben
Publicado 2011

Epidemiological and clinical characteristics of symptomatic hereditary transthyretin amyloid polyneuropathy: a global case series

por Waddington-Cruz, Márcia, Schmidt, Hartmut, Botteman, Marc F., Carter, John A., Stewart, Michelle, Hopps, Markay, Fallet, Shari, Amass, Leslie
Publicado 2019

Assessing the value of orphan drugs using conventional cost-effectiveness analysis: Is it fit for purpose?

por Postma, Maarten J., Noone, Declan, Rozenbaum, Mark H., Carter, John A., Botteman, Marc F., Fenwick, Elisabeth, Garrison, Louis P.
Publicado 2022

Cost-effectiveness of transfusion of platelet components prepared with pathogen inactivation treatment in the United States

por Bell, Christopher E., Botteman, Marc F., Gao, Xin, Weissfeld, Joel L., Postma, Maarten J., Pashos, Chris L., Triulzi, Darrell, Staginnus, Ulf
Publicado 2003

Economic value of atopic dermatitis prevention via infant formula use in high-risk Malaysian infants

por Bhanegaonkar, Abhijeet J, Horodniceanu, Erica G, Abdul Latiff, Amir Hamzah, Woodhull, Sanjay, Khoo, Phaik Choo, Detzel, Patrick, Ji, Xiang, Botteman, Marc F
Publicado 2015

Estimating the global prevalence of transthyretin familial amyloid polyneuropathy

por Schmidt, Hartmut H., Waddington‐Cruz, Márcia, Botteman, Marc F., Carter, John A., Chopra, Avijeet S., Hopps, Markay, Stewart, Michelle, Fallet, Shari, Amass, Leslie
Publicado 2018

Eliciting health state utilities for Dupuytren’s contracture using a discrete choice experiment

por Gu, Ning Yan, Botteman, Marc F, Gerber, Robert A, Ji, Xiang, Postema, Roelien, Wan, Yin, Sianos, Grzegorz, Anthony, Iain, Cappelleri, Joseph C, Szczypa, Piotr, van Hout, Ben
Publicado 2013

Landscape of Health-Related Quality of Life in Patients With Early-Stage Pancreatic Cancer Receiving Adjuvant or Neoadjuvant Chemotherapy: A Systematic Literature Review

por Macarulla, Teresa, Hendifar, Andrew E., Li, Chung-Pin, Reni, Michele, Riess, Hanno, Tempero, Margaret A., Dueck, Amylou C., Botteman, Marc F., Deshpande, Chinmay G., Lucas, Eleanor J., Oh, Do-Youn
Publicado 2020

Quality-adjusted survival with combination nal-IRI+5-FU/LV vs 5-FU/LV alone in metastatic pancreatic cancer patients previously treated with gemcitabine-based therapy: a Q-TWiST an...

por Pelzer, Uwe, Blanc, Jean-Frédéric, Melisi, Davide, Cubillo, Antonio, Von Hoff, Daniel D, Wang-Gillam, Andrea, Chen, Li-Tzong, Siveke, Jens T, Wan, Yin, Solem, Caitlyn T, Botteman, Marc F, Yang, Yoojung, de Jong, Floris A, Hubner, Richard A
Publicado 2017